What kind of consistency can industry expect from the FDA post pandemic? episode artwork

EPISODE · Jul 22, 2021 · 15 MIN

What kind of consistency can industry expect from the FDA post pandemic?

from The Biopharma Pod · host William Reed Ltd

How the US Food and Drug Administration (FDA) exercises flexibility has been an important and emerging issue for the past several years.

Episode metadata supplied by the publisher feed · Published Jul 22, 2021

Embed this episode

Ready to play

What kind of consistency can industry expect from the FDA post pandemic?

0:00 15:05

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Biopharma Pod?

This episode is 15 minutes long.

When was this The Biopharma Pod episode published?

This episode was published on July 22, 2021.

Can I download this The Biopharma Pod episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!